Suzuki Motor Corporation (SZKMY)

Longboard Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	849,278	842,710	952,839	958,452	964,315	1,024,553
Short-Term Investments	-	-	101,592	45,397	122,314	201,549
Cash & Short-Term Investments	849,278	842,710	1,054,431	1,003,849	1,086,629	1,226,102
Cash Growth	-2.96%	-20.08%	5.04%	-7.62%	-11.38%	102.87%
Accounts Receivable	596,032	590,303	558,768	483,908	427,215	444,463
Other Receivables	8,140	7,748	-	-	-	-
Receivables	604,172	598,051	558,768	483,908	427,215	444,463
Inventory	580,094	571,468	591,761	485,313	369,448	355,910
Other Current Assets	445,991	516,452	232,678	215,447	167,927	132,318
Total Current Assets	2,479,535	2,528,681	2,437,638	2,188,517	2,051,219	2,158,793
Property, Plant & Equipment	1,727,433	1,723,480	1,329,840	1,134,516	1,037,975	978,916
Long-Term Investments	1,490,221	1,499,589	1,523,526	1,116,883	917,972	754,831
Other Intangible Assets	178,420	178,162	7,804	3,839	3,396	2,351
Long-Term Deferred Tax Assets	61,585	63,742	85,444	132,605	143,346	140,922
Other Long-Term Assets	4	3	2	1	-	2
Total Assets	5,937,198	5,993,657	5,385,618	4,577,713	4,155,153	4,036,360
Accounts Payable	373,246	422,142	442,557	383,155	302,635	409,185
Accrued Expenses	-	-	263,288	232,157	201,979	228,809
Short-Term Debt	355,737	122,095	166,543	173,730	95,246	287,577
Current Portion of Long-Term Debt	-	175,738	290,237	173,319	95,579	281,277
Current Income Taxes Payable	50,592	52,789	67,120	44,242	55,155	32,138
Other Current Liabilities	783,487	829,793	511,301	480,833	505,923	449,476
Total Current Liabilities	1,563,062	1,602,557	1,741,046	1,487,436	1,256,517	1,688,462
Long-Term Debt	379,957	427,465	329,401	416,787	483,333	201,973
Long-Term Deferred Tax Liabilities	89,952	91,587	4,114	7,170	6,602	5,802
Other Long-Term Liabilities	134,500	137,719	112,751	91,155	80,564	46,061
Total Liabilities	2,215,037	2,305,587	2,247,222	2,069,095	1,891,482	2,004,396
Common Stock	138,370	138,370	138,370	138,370	138,318	138,262
Additional Paid-In Capital	59,006	59,013	69,084	138,180	143,369	143,400
Retained Earnings	2,680,075	2,619,684	2,030,090	1,813,209	1,638,726	1,519,826
Treasury Stock	-39,166	-39,166	-39,300	-19,396	-20,877	-21,027
Comprehensive Income & Other	160,545	192,759	292,810	7,694	-21,268	-92,868
Total Common Equity	2,998,830	2,970,660	2,491,054	2,078,057	1,878,268	1,687,593
Minority Interest	723,331	717,410	647,342	430,561	385,403	344,371
Shareholders' Equity	3,722,161	3,688,070	3,138,396	2,508,618	2,263,671	2,031,964
Total Liabilities & Equity	5,937,198	5,993,657	5,385,618	4,577,713	4,155,153	4,036,360
Total Debt	735,694	725,298	786,181	763,836	674,158	770,827
Net Cash (Debt)	113,584	117,412	268,250	240,013	412,471	455,275
Net Cash Growth	10.56%	-56.23%	11.77%	-41.81%	-9.40%	127.41%
Net Cash Per Share	58.87	60.86	138.67	123.53	212.34	234.45
Filing Date Shares Outstanding	1,929	1,930	1,930	1,944	1,942	1,942
Total Common Shares Outstanding	1,929	1,930	1,930	1,944	1,942	1,942
Working Capital	916,473	926,124	696,592	701,081	794,702	470,331
Book Value Per Share	1554.38	1539.49	1291.03	1068.89	966.94	868.89
Tangible Book Value	2,820,410	2,792,498	2,483,250	2,074,218	1,874,872	1,685,242
Tangible Book Value Per Share	1461.90	1447.16	1286.98	1066.91	965.19	867.68

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.